MEDEZE Welcomes ABRM Executive Delegation for Discussions on Advancing Collaboration in Medical Innovation
Dr. Veerapol Khemarangsan, Chief Executive Officer of MEDEZE Group Public Company Limited (“MEDEZE”), extended a warm welcome to a delegation from the American Board of Regenerative Medicine (ABRM), led by Dr. Rozina Badal Munir, Global Development Director of the American Society of Regenerative Medicine and the American Board of Regenerative Medicine. ABRM is a leading international organization committed to advancing standards in regenerative medicine through professional certification, education, and the development of cutting-edge cell and biotechnology-based therapies.
The delegation visited MEDEZE’s headquarters to explore opportunities for knowledge exchange and in-depth discussions on the future of medical innovation. During the visit, the group received briefings on Natural Killer (NK) cell banking, stem cell banking, and toured MEDEZE’s internationally certified laboratories.
This visit marks a significant milestone in the collaboration between world-class organizations, paving the way for new opportunities in knowledge development, international standardization, and the expansion of academic and business partnerships in the future.
The visit took place at MEDEZE Group Public Company Limited Headquarters, Phutthamonthon Sai 4.
IR Press Releases